Mandolin

The business targets the significant administrative bottlenecks in the healthcare system, particularly within infusion centers, specialty pharmacies, and health systems. Clients include large providers like Vivo Infusion, FlexCare Infusion, TwelveStone Health Partners, and Amber Specialty Pharmacy, with the platform deployed in over 700 clinic locations, serving more than 250,000 new patients annually. Mandolin's business model is centered on providing its AI platform to automate the end-to-end administrative tasks associated with infused and injected drugs, from patient referral to reimbursement.

Mandolin's core offering is a platform of AI agents that function as a digital workforce. These agents integrate directly into existing Electronic Health Records (EHRs), payer portals, and manufacturer hubs. The technology is designed to handle a variety of complex back-office tasks, such as performing benefits verification, navigating insurance portals, submitting prior authorizations, parsing faxes and clinical notes, and managing billing and claims. By automating these traditionally manual and time-consuming workflows, Mandolin aims to reduce treatment delays from weeks to days, lower operational costs for providers, and improve revenue cycle management. The company has secured significant financial backing, raising $40 million in a funding round from investors including Greylock Partners, SignalFire, Maverick, and SV Angel.